Abstract:Efficient monitoring and assessing the efficacy of vaccines against SARS‐CoV‐2 hinges on swiftly detecting its antibodies. Current methods, often intricate and reliant on nanomaterials, struggle with sensitivity and complexity, limiting their broad use. The immunosensing platform utilized in this work is tailored for quick and precise identification of SARS‐CoV‐2‐specific IgG and Nucleocapsid antibodies. Noteworthy, this platform marks only the second attempt at detecting N‐protein antibodies. Unlike its counterparts, it employs traditional self‐assembled monolayers to foster a selective bond between SARS‐CoV‐2‐specific Nucleocapsid antibodies and a gold electrode coated with the N‐protein antigen. Remarkably, despite eschewing nanomaterials, it matches existing sensors′ sensitivity over a broad detection range (0.025 to 1 ng/mL) with an outstanding limit of detection (0.019 ng/mL). The method's simplicity, reliant solely on immunocomplex reactions, underscores the possibility of achieving effective binding without complex functionalization, rendering it affordable, specific, and highly sensitive. By streamlining the process and eliminating additional steps, this platform presents a practical solution for SARS‐CoV‐2 antibody detection. Its success in N‐protein antibody detection suggests promise for widespread application, especially in resource‐limited settings, for outbreak surveillance and vaccine efficacy evaluation. Rapid and precise detection of SARS‐CoV‐2 antibodies is paramount for effective outbreak monitoring and vaccine efficacy assessment. While existing approaches for antibody detection often rely on complex electrochemical immunosensing with nanomaterial functionalization targeting S‐protein antibodies, their limitations in sensitivity and complexity have hindered widespread application. Here, we present a simplistic immunosensing platform designed for the rapid, and precise detection of SARS‐CoV‐2 specific IgG and Nucleocapsid antibodies. Notably, this study marks only the second exploration of SARS‐CoV‐2 N‐protein antibody detection. The platform utilizes traditional self‐assembled monolayers to establish selective bio‐affinity between SARS‐CoV‐2 specific Nucleocapsid antibodies and a gold electrode functionalized with the N‐protein antigen. Interestingly, despite the absence of nanomaterial functionalization, the developed platform achieves sensitivity comparable to existing sensors across a wide detection range (0.025 to 1 ng/mL) with an impressive limit of detection (0.019 ng/mL). The simplicity of the approach, relying solely on immunocomplex reactions, underscores that effective binding efficiency may be achieved in the absence of complex functionalization and determines its affordability, specificity, and high sensitivity. By eliminating the need for additional functionalization steps, the platform offers a streamlined solution for SARS‐CoV‐2 antibody detection and demonstrates the possibility of N‐protein antibody detection as a promising avenue for widespread application in SARS‐CoV‐2 outbreak monitoring and vaccine efficacy assessment particularly in underdeveloped regions.

Modular Label-Free Electrochemical Biosensor Loading Nature-Inspired Peptide toward the Widespread Use of COVID-19 Antibody Tests

Label-free Electrochemical Nanobiosensors Using Au-SPE for COVID-19 Detection: A Comparative Review of Different Biomarkers and Recognition Elements

Nanotechnology meets immunology towards a rapid diagnosis solution: the COVID-19 outbreak challenge

Label-free electrochemical immunosensor employing new redox probes/porous organic polymers/graphene oxide nanocomposite towards multiplex detection of three SARS-COV2-induced storming proteins for severe COVID-19 diagnosis

Utilizing COVID-19 as a Model for Diagnostics Using an Electrochemical Sensor

Sybodies as Novel Bioreceptors toward Field-Effect Transistor-Based Detection of SARS-CoV-2 Antigens

A Simplistic Label‐Free Electrochemical Immunosensing Approach for Rapid and Sensitive Detection of Anti‐SARS‐COV‐2 Nucleocapsid Antibodies

Novel approach based on GQD-PHB as anchoring platform for the development of SARS-CoV-2 electrochemical immunosensor

Diagnosis of viral infectious diseases through sensitive detection of human serum antibodies using a modified label-free electrochemical biosensor

Label-Free SARS-CoV-2 Detection on Flexible Substrates

A biosensor based on magnetoelastic waves for detection of antibodies in human plasma for COVID-19 serodiagnosis

An Effective SARS-CoV-2 Electrochemical Biosensor with Modifiable Dual Probes Using a Modified Screen-Printed Carbon Electrode

Aptamer-based electrochemical biosensor with S protein binding affinity for COVID-19 detection: Integrating computational design with experimental validation of S protein binding affinity

An Electrochemical Biosensor for SARS-CoV-2 Detection Via Its Papain-Like Cysteine Protease and the Protease Inhibitor Screening

Electrochemical Biosensor with Enhanced Antifouling Capability for COVID-19 Nucleic Acid Detection in Complex Biological Media

CRISPR-Cas12a-mediated Label-Free Electrochemical Aptamer-Based Sensor for SARS-CoV-2 Antigen Detection

Automated enzyme-linked immunosorbent assay for point-of-care COVID-19 testing

PEDOT-AuNPs-based impedimetric immunosensor for the detection of SARS-CoV-2 antibodies

Discovery of Peptidic Ligands against the SARS-CoV-2 Spike Protein and Their Use in the Development of a Highly Sensitive Personal Use Colorimetric COVID-19 Biosensor

SARS-CoV-2 virus label-free electrochemical nanohybrid MIP-aptasensor based on Ni3(BTC)2 MOF as a high-performance surface substrate

Electrochemical biosensor for the evaluation of monoclonal antibodies targeting the N protein of SARS-CoV-2 virus